3. Shikama N, Oguchi M, Isobe K, Nakamura K, Tamaki Y, Hasegawa M, Kodaira T, Sasaki S, Kagami Y; Japan Radiation Oncology Group (JAROG). A long-term follow-up study of prospective 80%-dose CHOP followed by involved-field radiotherapy in elderly lymphoma patients. Jpn J Clin Oncol. 41(6):764-9, 2011

4. Matsumoto S, Takayama T, Tamamoto T, Wakatsuki K, Enomoto K, Tanaka T, Migita K, Asakawa I, Hasegawa M, Nakajima Y. A comparison of surgery and radiation therapy for cT1 esophageal squamous cell carcinoma. Dis Esophagus. 24(6):411-7, 2011

5. Tanaka N, Fujimoto K, Shinkai T, Nakai Y, Kuwada M, Anai S, Miyake M, Hirayama A, Hasegawa M, Hirao Y. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis. Jpn J Clin Oncol. 41(10):1209-13, 2011

6. Tanaka T, Nishiofuku H, Tamamoto T, Sho M, Anai H, Sueyoshi S, Sakaguchi H, Hasegawa M, Nakajima Y, Kichikawa K. Intra-arterial chemoinfusion prior to chemoradiotherapy with full-dose systemic gemcitabine for management of locally advanced pancreatic cancer. Anticancer Res. 31(11):3909-12, 2011